RevealAI Lung

Mindshare Medical

RevealAI™ is Computer Assisted Diagnostic (CADx) software that reveals patterns within images and across patients. The analytics generate scores for the current patient by comparing abnormalities to other patients that have confirmed diagnostics. RevealAI-Lung provides a Malignancy Similarity Index (mSI) from lung CT scans that aids risk assessment. Graphs are provided that help interpret how lung nodules from the current patient relate to confirmed malignant or benign nodules.
Product specifications Information source: Public
Last updated: Jan. 27, 2020
General
Product name RevealAI Lung
Company Mindshare Medical
Subspeciality Chest
Modality CT
Disease targeted lung cancer
Key-features nodule malignancy similarity score
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE Certified, Class unknown
FDA No or not yet
Market presence
On market since 07-2019
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers